ACT CAPITAL MANAGEMENT, LLC - Q3 2022 holdings

$72.5 Million is the total value of ACT CAPITAL MANAGEMENT, LLC's 71 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 42.3% .

 Value Shares↓ Weighting
STAA SellSTAAR SURGICAL CO$15,719,000
-3.2%
222,800
-2.7%
21.69%
-4.5%
XOM BuyEXXON MOBIL CORP$7,124,000
+46.2%
81,600
+43.4%
9.83%
+44.3%
DVN  DEVON ENERGY CORP NEW$4,961,000
+9.1%
82,5000.0%6.85%
+7.7%
KRYS SellKRYSTAL BIOTECH INC$4,064,000
+4.9%
58,300
-1.2%
5.61%
+3.5%
ARWR SellARROWHEAD PHARMACEUTICALS INC$3,652,000
-23.2%
110,500
-18.1%
5.04%
-24.2%
AXSM NewAXSOME THERAPEUTICS INC$3,257,00073,000
+100.0%
4.50%
CVX BuyCHEVRON CORP NEW$3,233,000
+14.5%
22,500
+15.4%
4.46%
+13.0%
NewADTRAN HOLDINGS INC$2,937,000150,000
+100.0%
4.05%
 ENVVENO MED CORP$2,520,000
+66.1%
401,2000.0%3.48%
+63.9%
CLSD SellCLEARSIDE BIOMEDICAL INC$2,483,000
-26.2%
2,197,480
-4.0%
3.43%
-27.2%
LPI BuyLAREDO PETROLEUM INC$2,131,000
+141.6%
33,900
+164.8%
2.94%
+138.3%
ARCT SellARCTURUS THERAPEUTICS HLDGS$1,784,000
-50.0%
120,400
-46.9%
2.46%
-50.7%
EIGR SellEIGER BIOPHARMACEUTICALS INC$1,770,000
+12.4%
235,000
-6.0%
2.44%
+10.9%
VRNA NewVERONA PHARMAsponsored ads$1,467,000143,500
+100.0%
2.02%
ET  ENERGY TRANSFER L P$1,410,000
+10.6%
127,8000.0%1.95%
+9.1%
FANG BuyDIAMONDBACK ENERGY INC$1,265,000
+160.8%
10,500
+162.5%
1.75%
+157.5%
MYOV SellMYOVANT SCIENCES LTD$1,078,000
+33.4%
60,000
-7.7%
1.49%
+31.7%
INMB SellINMUNE BIO INC$937,000
-34.0%
151,100
-5.9%
1.29%
-34.9%
IKT  INHIBIKASE THERAPEUTICS INC$853,000
+22.6%
937,5000.0%1.18%
+21.0%
ROKU BuyROKU INC$761,000
+65.4%
13,500
+141.1%
1.05%
+63.3%
AFMD  AFFIMED N V$636,000
-25.6%
308,8000.0%0.88%
-26.6%
CMBM NewCAMBIUM NETWORKS CORPORATION$582,00034,400
+100.0%
0.80%
TMDX NewTRANSMEDICS GROUP INC$522,00012,500
+100.0%
0.72%
SSYS SellSTRATASYS LTD$504,000
-46.2%
35,000
-30.0%
0.70%
-46.9%
CSBR  CHAMPIONS ONCOLOGY INC$469,000
-6.2%
62,5000.0%0.65%
-7.4%
ICAD  ICAD INC$431,000
-47.4%
205,0000.0%0.60%
-48.1%
U SellUNITY SOFTWARE INC$398,000
-58.9%
12,500
-52.5%
0.55%
-59.5%
VIST  VISTA OIL &GAS SAB DE CV SPON ADS EACH REP 1 ORD SHS SER Asponsored ads$391,000
+27.4%
41,5000.0%0.54%
+25.9%
DEN NewDENBURY INC COM$345,0004,000
+100.0%
0.48%
ZETA SellZETA GLOBAL HOLDINGS CORPcl a$340,000
+3.7%
51,500
-29.0%
0.47%
+2.2%
SQ NewBLOCK INCcl a$330,0006,000
+100.0%
0.46%
FUBO SellFUBOTV INC$284,000
+4.4%
80,000
-27.3%
0.39%
+3.2%
SellQUALTEK SERVICES INC$278,000
-37.4%
138,500
-53.8%
0.38%
-38.2%
OCX  ONCOCYTE CORPORATION$241,000
-18.9%
330,0000.0%0.33%
-19.8%
CHK NewCHESAPEAKE ENERGY CORP$236,0002,500
+100.0%
0.33%
NewRUMBLE INC$234,00019,100
+100.0%
0.32%
LPTX  LEAP THERAPEUTICS INC$233,000
-23.6%
265,0000.0%0.32%
-24.6%
ONCT  ONCTERNAL THERAPEUTICS INC$187,000
-19.7%
210,0000.0%0.26%
-20.9%
CRDF  CARDIFF ONCOLOGY INC$186,000
-29.8%
120,6000.0%0.26%
-30.7%
SURF  SURFACE ONCOLOGY INC$177,000
-36.8%
170,5000.0%0.24%
-37.8%
SNOW NewSNOWFLAKE INCcl a$170,0001,000
+100.0%
0.24%
AWH SellASPIRA WOMENS HEALTH INC$155,000
-59.2%
417,123
-35.4%
0.21%
-59.7%
DOCN SellDIGITALOCEAN HLDGS INC$145,000
-65.0%
4,000
-60.0%
0.20%
-65.5%
SAVA NewCASSAVA SCIENCES INC$142,0003,400
+100.0%
0.20%
MRKR  MARKER THERAPEUTICS INC$131,000
+12.0%
354,4000.0%0.18%
+10.4%
NLTX  NEOLEUKIN THERAPEUTICS INC$127,000
-38.0%
199,0000.0%0.18%
-39.0%
MDNA  MEDICENNA THERAPEUTICS CORP$124,000
-28.3%
149,0700.0%0.17%
-29.3%
GRTS  GRITSTONE BIO INC$122,000
+6.1%
47,5000.0%0.17%
+4.3%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$97,000
-36.6%
90,0000.0%0.13%
-37.4%
 DRAGANFLY INC$95,000
-22.1%
135,0000.0%0.13%
-23.4%
YCBDPRA  CBDMD INC8% ser a cum pfd$77,000
-3.8%
22,0000.0%0.11%
-5.4%
NewCELLECTAR BIOSCIENCES INC$73,00021,750
+100.0%
0.10%
ENLV  ENLIVEX THERAPEUTICS LTD$64,000
-5.9%
15,0000.0%0.09%
-7.4%
SDPI  SUPERIOR DRILLING PRODS INC$54,000
-31.6%
80,0000.0%0.08%
-31.8%
CTSO  CYTOSORBENTS CORP$48,000
-37.7%
35,0000.0%0.07%
-38.9%
OYST  OYSTER PT PHARMA INC$48,000
+29.7%
8,5000.0%0.07%
+26.9%
TCON  TRACON PHARMACEUTICALS INC$48,000
-15.8%
28,5000.0%0.07%
-17.5%
YALA  YALLA GROUP LTDads$44,000
-17.0%
13,5000.0%0.06%
-17.6%
SIOX  SIO GENE THERAPIES INC$41,000
-22.6%
146,5000.0%0.06%
-23.0%
SQZ  SQZ BIOTECHNOLOGIES CO$36,000
-29.4%
16,0000.0%0.05%
-29.6%
PDSB  PDS BIOTECHNOLOGY CORP$36,000
-18.2%
12,0000.0%0.05%
-19.4%
CYT  CYTEIR THERAPEUTICS INC$29,000
-35.6%
15,0000.0%0.04%
-36.5%
YCBD  CBDMD INC$28,000
-49.1%
125,0000.0%0.04%
-49.4%
BLRX  BIOLINE RX LTDsponsored ads$25,000
-28.6%
27,5000.0%0.04%
-28.6%
TIL  INSTIL BIO INC$24,000
+4.3%
5,0000.0%0.03%
+3.1%
NewSYROS PHARMACEUTICALS INC$23,0003,499
+100.0%
0.03%
ARAV  ARAVIVE INC$15,000
-21.1%
18,7770.0%0.02%
-22.2%
 AIRSCULPT TECHNOLOGIES INC$10,000
+11.1%
1,5000.0%0.01%
+7.7%
RNAZ  TRANSCODE THERAPEUTICS INC$7,000
-12.5%
6,5000.0%0.01%
-9.1%
GTH  GENETRON HOLDINGS LIMITEDads$6,000
-53.8%
7,5000.0%0.01%
-55.6%
ATRA SellATARA BIOTHERAPEUTICS INC$3,000
-95.8%
900
-90.2%
0.00%
-96.0%
MOGO ExitMOGO INC$0-19,491
-100.0%
-0.02%
KERN ExitAKERNA CORP$0-128,000
-100.0%
-0.02%
ExitLOTTERY COM INC*w exp 05/09/202$0-125,000
-100.0%
-0.04%
SYRS ExitSYROS PHARMACEUTICALS INC$0-35,000
-100.0%
-0.05%
HSDT ExitHELIUS MED TECHNOLOGIES INC$0-35,263
-100.0%
-0.06%
AMPE ExitAMPIO PHARMACEUTICALS INC$0-291,500
-100.0%
-0.07%
ExitLOTTERY COM INC$0-56,000
-100.0%
-0.09%
CLRB ExitCELLECTAR BIOSCIENCES INC$0-217,500
-100.0%
-0.12%
IMTX ExitIMMATICS N V$0-10,300
-100.0%
-0.13%
AUD ExitAUDACY INCcl a$0-97,500
-100.0%
-0.13%
AMZN ExitAMAZON.COM INC$0-1,000
-100.0%
-0.15%
RYTM ExitRHYTHM PHARMACEUTICALS INC$0-27,500
-100.0%
-0.16%
LTHM ExitLIVENT CORP$0-6,000
-100.0%
-0.19%
NTRA ExitNATERA INC$0-7,000
-100.0%
-0.35%
AUPH ExitAURINIA PHARMACEUTICALS INC$0-51,000
-100.0%
-0.72%
MRVI ExitMARAVAI LIFESCIENCES HLDGS INC$0-24,500
-100.0%
-0.97%
CF ExitCF INDUSTRIES HOLDINGS INC$0-9,000
-100.0%
-1.08%
LNTH ExitLANTHEUS HOLDINGS INC$0-12,900
-100.0%
-1.19%
IDYA ExitIDEAYA BIOSCIENCES INC$0-173,500
-100.0%
-3.35%
ADTN ExitADTRAN INC$0-150,000
-100.0%
-3.68%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO6Q3 202222.7%
ARROWHEAD PHARMACEUTICALS INC6Q3 202210.1%
ARCTURUS THERAPEUTICS HLDGS6Q3 202212.8%
CLEARSIDE BIOMEDICAL INC6Q3 20227.7%
KRYSTAL BIOTECH INC6Q3 20225.6%
FUBOTV INC6Q3 20224.4%
EIGER BIOPHARMACEUTICALS INC6Q3 20222.4%
ASPIRA WOMENS HEALTH INC6Q3 20223.3%
ICAD INC6Q3 20222.0%
INHIBIKASE THERAPEUTICS INC COM6Q3 20221.7%

View ACT CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ACT CAPITAL MANAGEMENT, LLC Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HyreCar Inc.December 09, 2020230,0001.3%
SOLIGENIX, INC.February 07, 20201,221,4995.6%
EDISON NATION, INC.April 18, 2019214,4543.8%
Hancock Jaffe Laboratories, Inc.December 26, 2018503,5004.3%
Ampio Pharmaceuticals, Inc.August 10, 20181,210,7851.4%
Xspand Products Lab, Inc.May 09, 2018405,0009.3%
CROSSROADS SYSTEMS INCJune 16, 201759,0534.8%
ALLDIGITAL HOLDINGS, INC.Sold outJanuary 23, 201700.0%
MOBIVITY HOLDINGS CORP.January 06, 20171,734,9164.8%
Akers Biosciences IncJanuary 25, 2016213,5003.9%

View ACT CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2022-11-03
13F-HR2022-08-12
13F-HR2022-05-11
13F-HR2022-02-03
13F-HR2021-11-16
13F-HR2021-08-16
SC 13G/A2020-12-09
SC 13G/A2020-02-10
SC 13G/A2020-02-07
SC 13G/A2020-02-07

View ACT CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export ACT CAPITAL MANAGEMENT, LLC's holdings